Literature DB >> 18294242

Fluoroquinolone-resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread.

N Grude1, L Strand, H Mykland, F L Nowrouzian, J Nyhus, A Jenkins, B-E Kristiansen.   

Abstract

Prevalence, resistance profiles, virulence gene complements, and phylogenetic and clonal affinities of fluoroquinolone-resistant Escherichia coli from urinary tract infections (UTIs) in Norway were investigated. Of 7302 E. coli UTI isolates from 2003, 1.2% were fluoroquinolone-resistant; 35 of these fluoroquinolone-resistant isolates were included in the present study. The isolates were predominantly multiresistant, carried few virulence factors, and tended to belong to the less-virulent phylogroups A and B1. Although the isolates were genetically heterogeneous, there was evidence of a limited degree of clonal dissemination.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18294242     DOI： 10.1111/j.1469-0691.2008.01952.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  6 in total

1.  Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.

Authors:  P Rattanaumpawan; P Tolomeo; W B Bilker; N O Fishman; E Lautenbach
Journal:  J Hosp Infect       Date:  2010-12       Impact factor: 3.926

Review 2.  Defining relatedness in studies of transmission of antimicrobial-resistant organisms: variability in definitions across studies and impact of different approaches on study conclusions.

Authors:  Rachel M Greenblatt; Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-11-21       Impact factor: 3.254

3.  The world's microbiology laboratories can be a global microbial sensor network.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Biomedica       Date:  2014-04       Impact factor: 0.935

4.  Quinolone resistance in Escherichia coli from Accra, Ghana.

Authors:  Sreela S Namboodiri; Japheth A Opintan; Rebeccah S Lijek; Mercy J Newman; Iruka N Okeke
Journal:  BMC Microbiol       Date:  2011-02-27       Impact factor: 3.605

5.  The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.

Authors:  Lance B Price; James R Johnson; Maliha Aziz; Connie Clabots; Brian Johnston; Veronika Tchesnokova; Lora Nordstrom; Maria Billig; Sujay Chattopadhyay; Marc Stegger; Paal S Andersen; Talima Pearson; Kim Riddell; Peggy Rogers; Delia Scholes; Barbara Kahl; Paul Keim; Evgeni V Sokurenko
Journal:  mBio       Date:  2013-12-17       Impact factor: 7.867

6.  High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?

Authors:  Linda Strand; Andrew Jenkins; Ingrid Høgli Henriksen; Anne Gry Allum; Nils Grude; Bjørn Erik Kristiansen
Journal:  BMC Res Notes       Date:  2014-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.